For Dieters, Obesity Drugs Are a Magic Pill. These Consumer Stocks Could Lose.
If weight-loss drugs become multibillion-dollar blockbusters, snack makers and beer companies could take a hit, analysts say.
Source: marketwatch.com
Stay updated with breaking news from Daniel Acker Bloomberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If weight-loss drugs become multibillion-dollar blockbusters, snack makers and beer companies could take a hit, analysts say.
Americans are drowning in credit card debt as stubborn inflation makes the cost of everyday necessities more expensive.
Jefferies analyst Akash Tewari upgraded shares of Eli Lilly to Buy from Hold.
The newly retired are getting help from coaches who specialize in helping CEOs figure out what to do after the pension kicks in. Read on.
A typical home sold for about $382,000 during the four weeks ending on July 23.